Using decentralized elements in clinical trials can make research faster, more efficient and patient centric, according to three new reports that add to the growing evidence supporting the use of this increasingly popular practice.
Regulators Are Taking Step To Support DCTs
The use of wearables, telemedicine and other decentralized elements that eliminate or reduce the need for site visits by trial...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?